NYSE:BBWI
NYSE:BBWISpecialty Retail

Will Bath & Body Works' (BBWI) New Leadership Shift Its Digital and Omnichannel Trajectory?

Bath & Body Works recently appointed Maly Bernstein as Chief Commercial Officer and Samantha Charleston as Chief Human Resources Officer, effective November 12, 2025, in a move aimed at advancing its ongoing transformation plans. This leadership update brings seasoned expertise in digital and omnichannel retail, as well as large-scale organizational change, directly addressing some of the company’s key operational and market challenges. We’ll now explore how the addition of Bernstein’s...
NasdaqGS:GLRE
NasdaqGS:GLREInsurance

Greenlight Capital Re (GLRE): Losses Narrow 25.2% Annually, Valuation Remains Discounted vs Peers

Greenlight Capital Re (GLRE) remains unprofitable, but the company has narrowed its losses over the last five years at an annual rate of 25.2%. Despite the ongoing challenges to net profit margin, the stock is drawing investor attention thanks to a low Price-To-Sales Ratio of 0.6x versus a peer average of 4.9x and a trading price of $11.95, well below an estimated fair value of $20.06. With risk sentiment steady and no major negative headlines, the current results put the spotlight on...
NasdaqGS:XMTR
NasdaqGS:XMTRTrade Distributors

Xometry (XMTR): Persistent Losses Challenge Optimism on Expected 99% Annual Earnings Growth

Xometry (XMTR) remains unprofitable, with net losses rising at an annual rate of 2.3% over the past five years and no meaningful progress on profit margins. Despite persistent losses, revenue is forecast to increase by 14.8% per year, which would outpace the broader US market's 10.5% growth. Earnings are projected to jump 99% annually, with profitability expected within three years. Investors attracted to Xometry's rapid top-line growth and the promise of a turnaround must weigh this optimism...
NYSE:BOW
NYSE:BOWInsurance

Bowhead Specialty Holdings (BOW): Net Margin Rises to 10.1% Reinforcing Bullish Growth Narratives

Bowhead Specialty Holdings (BOW) posted an impressive set of headline numbers, with earnings forecast to grow at 23.5% per year, well above the US market average of 16%, and revenue projected to rise 19.3% annually compared to the broader market’s 10.5%. Net profit margin improved to 10.1% from last year’s 7.6%, signaling a clear strengthening in profitability. With earnings quality described as high and expectations set for robust growth, investors are likely to focus on the company's...
NasdaqGS:BVS
NasdaqGS:BVSMedical Equipment

Bioventus (BVS): $17.3M One-Time Loss Raises Questions About Quality of New Profitability

Bioventus (BVS) recently swung to profitability in the past year, despite an average earnings decline of 16.6% per year over the last five years. The bottom line was affected by a non-recurring loss of $17.3 million for the twelve months ending September 27, 2025. Although revenue is forecast to grow at 6.1% annually, this pace trails the broader US market's 10.5% average. Trading at $7.55, the stock sits well below its estimated fair value of $17.96 and also below analyst targets. Its high...
NYSE:INGR
NYSE:INGRFood

Ingredion (INGR) Edges Profit Margin Higher, Tempered Growth Challenges Bullish Narratives

Ingredion (NYSE:INGR) reported a net profit margin of 9.1%, just above last year’s 9%. Over the past five years, the company has delivered robust annual earnings growth of 23.9%. Looking ahead, forecasts point to much slower annual increases of 1.8% for earnings and 2% for revenue, trailing the broader US market averages of 16% and 10.5% respectively. Investors may still find value here, as the stock’s price-to-earnings ratio of 10.5x comes in well below both the peer and industry averages,...
NYSE:AMPX
NYSE:AMPXElectrical

Amprius Technologies (AMPX): Assessing Valuation After ESAero Partnership and CFO Appointment

Amprius Technologies (AMPX) has caught investor attention after announcing a strategic partnership with ESAero to bring its advanced silicon-anode batteries to unmanned aerial vehicles. The company also named Ricardo C. Rodriguez as its new CFO, marking operational progress. See our latest analysis for Amprius Technologies. It has certainly been a big year for Amprius Technologies. After a long period out of the spotlight, the stock has staged a dramatic comeback with a 323.08% year-to-date...
NasdaqGS:SLAB
NasdaqGS:SLABSemiconductor

Silicon Labs (SLAB): High Growth Forecasts Meet Profitability Challenges as Earnings Season Approaches

Silicon Laboratories (SLAB) remains unprofitable, with losses expanding at an average rate of 17.3% per year over the last five years. Shares currently trade at $126.77, a premium to the estimated fair value of $66.29. The Price-to-Sales ratio stands at 5.6x compared to an industry average of 5.3x. Looking ahead, investors are eyeing the impressive forecast for both revenue and earnings growth, with profitability expected within the next three years. See our full analysis for Silicon...
NasdaqGS:DRVN
NasdaqGS:DRVNConsumer Services

Driven Brands (DRVN) Trading at 1x Sales Ratio Highlights Discount Versus Peers Heading Into Earnings

Driven Brands Holdings (DRVN) remains unprofitable, with losses accelerating at an average rate of 48.1% per year over the past five years. However, analysts expect earnings to grow by 56.02% annually, projecting the company will achieve profitability within the next three years. This outlook stands above market averages. Revenue is forecast to grow 4% per year, which is slower than the 10.5% US market average, but the company’s valuation continues to attract attention as shares trade well...
NasdaqGS:QURE
NasdaqGS:QUREBiotechs

uniQure (QURE): Examining Valuation Following Recent Share Price Volatility

uniQure (QURE) shares have been on the move recently, drawing renewed attention from investors tracking biotech stocks. Trading activity suggests a sizeable shift in sentiment. This has prompted many to take a fresh look at the company’s valuation and growth outlook. See our latest analysis for uniQure. uniQure’s share price has been exceptionally volatile, with a steep 56.5% loss this week giving back much of its recent surge. Even so, momentum over the longer term remains significant, with...
NYSE:ADT
NYSE:ADTConsumer Services

ADT (ADT) Margin Expansion Reinforces Value Narrative, Offsets Concerns on Financial Position

ADT (ADT) reported a net profit margin of 12.8%, up from 11% the previous year, highlighting a notable improvement in profitability. While the company posted 23.3% earnings growth for the most recent year, this is below its impressive five-year annual average of 67.7%. With shares trading at $8.08, well under the estimated fair value of $19.86, investors are weighing the appeal of rising margins and an attractive valuation against concerns over ADT’s less favorable financial position. See our...
NasdaqGM:DAVE
NasdaqGM:DAVEConsumer Finance

Dave (DAVE) Net Profit Margin Climbs to 29.8%, Reinforcing Bullish Community Narratives

Dave (DAVE) posted a net profit margin of 29.8%, jumping from 12.9% last year, as revenue is projected to grow at 15% annually, outpacing the US market’s 10.5% average. Over the past year, earnings soared 255.6%, far exceeding the company’s already impressive five-year average of 43.4% annual growth. With high-quality earnings, improved margins, and momentum on both the revenue and profit fronts, investors are likely to zero in on these operational gains as a sign of sustained business...
NYSE:HOG
NYSE:HOGAuto

Harley-Davidson (HOG) Valuation Discount Clashes With Negative Earnings Outlook in Latest Filings

Harley-Davidson (HOG) is facing a challenging road ahead, with the latest filings pointing to a 3.6% annual drop in revenue and a steeper 11.8% annual decline in earnings expected over the next three years. The company’s net profit margin sits at 10.7%, just below last year’s 10.8%, capping off a period where five-year annual earnings growth averaged 7.8% but has now turned negative over the last twelve months. For investors, these results set the stage for tough decisions as attractive value...
NYSE:PAY
NYSE:PAYDiversified Financial

Paymentus (PAY): Margin Uptick Reinforces High-Growth Narrative, But Valuation Remains a Sticking Point

Paymentus Holdings (PAY) posted net profit margins of 5.3%, a slight uptick from last year's 5.2%. Over the past five years, earnings have surged at an impressive 57.4% annual rate, but the latest annual earnings growth of 47% fell short of this pace. Looking ahead, analysts expect earnings to grow 28.1% per year and revenue to expand 19.6% annually. Both figures outpace the broader US market, yet shares trade well above DCF-based estimates with a price-to-earnings ratio of 76.1x. See our...
NasdaqGS:TSAT
NasdaqGS:TSATTelecom

Telesat (TSAT) Losses Accelerate 54% Annually, Challenging Bullish Revenue Growth Narrative

Telesat (TSAT) remains unprofitable, with losses accelerating at an average rate of 54.1% a year over the past five years. Despite the red ink, the company’s revenue is forecast to grow 23.6% annually, outpacing the US market’s 10.5% projection. While top-line expansion is impressive, TSAT’s net profit margin has yet to improve and the company is expected to stay unprofitable for at least the next three years, putting sustained pressure on investor confidence. See our full analysis for...
NasdaqCM:AHCO
NasdaqCM:AHCOHealthcare

AdaptHealth (AHCO) Profitability Marks Turnaround, Challenging Bearish Valuation Narratives

AdaptHealth (AHCO) recently turned profitable, with its net profit margin shifting notably over the past year. Despite a -16.2% average annual earnings growth over the last five years, forecasts now call for earnings to grow at 23.1% per year, outpacing the broader US market’s 16%. While revenue is expected to rise 7.3% per year in the coming period, which trails the US average, high earnings quality and significant near-term profit growth are clear upside drivers for investors who see value...
NYSE:GPN
NYSE:GPNDiversified Financial

Global Payments (GPN) Net Margin Tops Expectations, Reinforcing Bullish Narratives on Profit Quality

Global Payments (GPN) posted a net profit margin of 16.2%, up from 13.8% a year ago, and earnings have grown at an impressive 24% per year over the past five years, with a standout 34.4% gain in the last year alone. While revenue and projected annual earnings are expected to grow at a slower pace than the broader US market, the company’s high earnings quality and forward profit growth continue to draw attention as shares trade below estimates of fair value and at a Price-To-Earnings ratio of...
NasdaqGS:BWIN
NasdaqGS:BWINInsurance

Did Baldwin Insurance Group's (BWIN) Downward Earnings Revision Just Shift Its Investment Narrative?

Baldwin Insurance Group recently announced a downward revision of its full-year 2025 revenue and earnings forecasts ahead of its Q3 earnings release on November 4, 2025. The shift from positive to negative full-year earnings outlook comes shortly after the company previously missed quarterly earnings expectations, raising concerns about potential headwinds in its near-term financial performance. To assess the implications of Baldwin's revised outlook, we’ll explore how lower full-year...
NYSE:MED
NYSE:MEDPersonal Products

Medifast (MED) Profit Margin Plunges to 0.06%, Undermining Recovery Narratives

Medifast (MED) is facing a tough outlook, with both revenue and earnings forecast to decline sharply over the next three years. Revenue is expected to decrease by 12.5% per year, and earnings are projected to fall by 146.7% annually, following a recent year in which net profit margins slipped to just 0.06%, down from 1.1% last year. The company also recorded a one-off loss of $12.5 million in the last twelve months, adding extra pressure to already weakening earnings. In fact, average annual...
NYSE:SPIR
NYSE:SPIRProfessional Services

Spire Global (SPIR) Turns Profitable, But Forecast 70% Earnings Decline Challenges Bullish Narratives

Spire Global (SPIR) recently became profitable, with its net profit margin turning positive over the past year. Despite crossing into the black, earnings are forecast to decline sharply at an annual rate of 70% over the next three years, even as revenue is projected to grow just 2.5% per year, lagging far behind the US market average of 10.5%. For investors, this means the company is coming off a milestone of positive earnings, but expectations remain muted due to forecasts for falling...
NYSEAM:CMT
NYSEAM:CMTChemicals

Core Molding Technologies (CMT): Margin Drop Contrasts With Bold Three-Year EPS Growth Outlook

Core Molding Technologies (CMT) is aiming for a massive 46.5% annual EPS growth rate over the next three years, which easily outpaces the US market average of 16%. This outlook comes as the company posts a forecasted 6.4% revenue growth per year, lagging the US market’s 10.5% average, and a net profit margin of 3.1%, down from 4.9% a year ago. After growing earnings at 20.7% per year over the last five years, CMT enters this period with a high-quality earnings track record but faces margin...
NYSE:VPG
NYSE:VPGElectronic

Vishay Precision Group (VPG) Margin Decline Challenges Bullish Growth Narrative Despite Upbeat Forecasts

Vishay Precision Group (VPG) reported a net profit margin of 2.7%, dropping from last year’s 4.2%. Over the past five years, the company’s earnings have declined by 7.6% each year, with the latest period benefiting from a one-off $4.4 million gain as of September 27, 2025. However, with earnings expected to rise 54.7% per year going forward, investors are weighing persistent pressure on margins against forecasts that point to a significant rebound. See our full analysis for Vishay Precision...
NasdaqGS:TSHA
NasdaqGS:TSHABiotechs

Taysha Gene Therapies (TSHA): Revenue Forecast to Grow 70.5% Annually, Balancing Risks and Valuation

Taysha Gene Therapies (TSHA) remains unprofitable, but its revenue is forecast to grow rapidly by 70.5% per year, far outpacing the broader US market's expected 10.5% annual growth. Over the past five years, the company has managed to cut its losses at a 7.5% annual rate, even as it is projected to stay in the red for at least the next three years. With shares recently trading at $4.27, below an estimated fair value of $20.71, investors are weighing the promise of significant top-line growth...
NasdaqGS:PTLO
NasdaqGS:PTLOHospitality

Portillo’s (PTLO) Margin Decline Challenges Bullish Narratives Despite Strong Earnings Growth

Portillo’s (PTLO) is forecast to grow revenue at 8.5% per year, which trails the broader US market’s pace of 10.5%. Despite this, the company’s earnings are expected to climb 16.9% per year, a notch above the market’s 16% average, while net profit margins edged down to 3.4% from last year’s 3.6%. Investors are watching this mix of slower sales growth but faster earnings momentum, especially as the company maintains modest profitability and a valuation that sits between direct peers and the...